This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A randomized phase II trial comparing pazopanib wi...
Clinical trial

A randomized phase II trial comparing pazopanib with doxorubicin as first line treatment in elderly patients with metastatic or advanced soft tissue sarcoma

Read time: 1 mins
Last updated:4th Jun 2012
To show that progression-free survival in the pazopanib group is not inferior to that in the doxorubicin group
Category Value
Study start date 2012-06-04

View full details